Vestor Capital’s Bristol-Myers Squibb BMY Stock Holding History

Vestor Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Sell	2,798 -171,459	-98%	-$9.85M	0.04%	111
2026 Q1	$10.6M	Buy	+174,257	New	+$10.2M	0.76%	40
2022 Q2	–	Sell	-566	Closed	-$41K	–	213
2022 Q1	$41K	Buy	+566	New	+$38K	﹤0.01%	227
2021 Q4	–	Sell	-66,872	Closed	-$3.96M	–	235
2021 Q3	$3.96M	Buy	+66,872	New	+$4.4M	0.41%	61
2020 Q1	–	Sell	-3,660	Closed	-$235K	–	140
2019 Q4	$235K	Buy	3,660 +2,500	+216%	+$143K	0.04%	94
2019 Q3	$59K	Buy	+1,160	New	+$54.5K	0.01%	116
2019 Q2	–	Sell	-1,443	Closed	-$69K	–	136
2019 Q1	$69K	Buy	+1,443	New	+$71.9K	0.01%	116

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vestor Capital's BMY Position: Q2 2026 in Review

Vestor Capital reduced its Bristol-Myers Squibb (BMY) stake by 98% in Q2 2026, selling an estimated $9.85M and leaving 2,798 shares worth $606K. The position accounts for 0.04% of the portfolio, ranked #111.

Vestor Capital first reported a position in BMY in Q1 2019 and has held it in 7 quarters since. The position peaked at $10.6M in Q1 2026. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Vestor Capital held 2,798 shares of Bristol-Myers Squibb worth $606K as of Q2 2026.
Vestor Capital sold 171,459 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.85M.
Bristol-Myers Squibb made up 0.04% of Vestor Capital's portfolio in Q2 2026, its #111 holding.
Vestor Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 7 quarters since.
Vestor Capital's Bristol-Myers Squibb position peaked at $10.6M in Q1 2026.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.